$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

High YBX1 expression indicates poor prognosis and promotes cell migration and invasion in nasopharyngeal carcinoma

Experimental cell research, v.361 no.1, 2017년, pp.126 - 134  

Zhou, Lei-lei (Department of Oncology, Huai'an First People's Hospital, Nanjing Medical University) ,  Ni, Jie (Nanjing Medical University Affliated Cancer Hospital, Department of Clinical Cancer Research Center, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research) ,  Feng, Wan-ting (Department of Oncology, Huai'an First People's Hospital, Nanjing Medical University) ,  Yao, Rong (Department of Oncology, Huai'an First People's Hospital, Nanjing Medical University) ,  Yue, Shun (Department of Oncology, Huai'an First People's Hospital, Nanjing Medical University) ,  Zhu, Ya-ning (Department of Pathology, Huai'an First People's Hospital, Nanjing Medical University) ,  Tang, Hai-yan (Department of Pathology, Huai'an First People's Hospital, Nanjing Medical University) ,  Lv, Ling-yun (Department of Otolaryngology, Huai'an First People's Hospital, Nanjing Medical University) ,  Feng, Ji-feng (Nanjing Medical Universit) ,  Zhu, Wei-guo

Abstract AI-Helper 아이콘AI-Helper

Abstract Y-box binding protein-1 (YBX1) is a multifunctional protein and often acts as an indicator of poor prognosis in cancers. Increasing evidence has shown that the levels of YBX1 protein were closely associated with multidrug resistance, relapse, metastasis and poor prognosis in cancers. Howev...

주제어

참고문헌 (43)

  1. Cancer Cell Lo 5 423 2004 10.1016/S1535-6108(04)00119-9 Focus on nasopharyngeal carcinoma 

  2. Chin. J. Cancer Cao 30 114 2011 10.5732/cjc.010.10377 The prevalence and prevention of nasopharyngeal carcinoma in China 

  3. Eur. Ann. Otorhinolaryngol. Head Neck Dis. Bensouda 128 79 2011 10.1016/j.anorl.2010.10.003 Treatment for metastatic nasopharyngeal carcinoma 

  4. Chin. J. Cancer Han 29 145 2010 10.5732/cjc.009.10332 Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy 

  5. Biochim. Biophys. Acta Geiger 1796 293 2009 Metastasis mechanisms 

  6. Cancer Res. Gao 72 4883 2012 10.1158/0008-5472.CAN-12-1223 Microenvironmental regulation of epithelial-mesenchymal transitions in cancer 

  7. Cancer Sci. Iwatsuki 101 293 2010 10.1111/j.1349-7006.2009.01419.x Epithelial-mesenchymal transition in cancer development and its clinical significance 

  8. J. Mammary Gland Biol. Neoplasia Micalizzi 15 117 2010 10.1007/s10911-010-9178-9 Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression 

  9. Oral Oncol. Smith 49 287 2013 10.1016/j.oraloncology.2012.10.009 Epithelial to mesenchymal transition in head and neck squamous cell carcinoma 

  10. Biology Ksiazkiewicz 79 195 2012 Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells 

  11. Oncogene Pistore 2017 10.1038/onc.2017.159 DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells 

  12. Int. J. Oncol. Li 51 158 2017 10.3892/ijo.2017.4007 miR181b5p mediates TGFbeta1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells 

  13. Oncotarget Ying 8 18348 2017 10.18632/oncotarget.15442 MicroRNA-137 inhibits BMP7 to enhance the epithelial-mesenchymal transition of breast cancer cells 

  14. Cell Death Dis. Zhang 8 e2838 2017 10.1038/cddis.2017.114 Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis 

  15. Cold Spring Harbor Perspect. Biol. Morikawa 8 2016 10.1101/cshperspect.a021873 TGF-beta and the TGF-beta family: context-dependent roles in cell and tissue physiology 

  16. J. Mol. Histol. Zhang 43 297 2012 10.1007/s10735-012-9392-4 Evaluation of the prognostic value of TGF-beta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays 

  17. Mol. Cancer Salvo 13 112 2014 10.1186/1476-4598-13-112 Combined targeting of TGF-beta1 and integrin beta3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer 

  18. Cell Res. Xu 19 156 2009 10.1038/cr.2009.5 TGF-beta-induced epithelial to mesenchymal transition 

  19. Mol. Cancer Lyu 13 51 2014 10.1186/1476-4598-13-51 TGFbetaR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness 

  20. Sci. Rep. Wu 7 42507 2017 10.1038/srep42507 High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-beta1-induced epithelia-to-mesenchymal transition 

  21. Cell Yang 117 927 2004 10.1016/j.cell.2004.06.006 Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis 

  22. Cancer Res. Shi 69 7180 2009 10.1158/0008-5472.CAN-08-4470 Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition 

  23. Int. J. Dev. Biol. Peinado 48 365 2004 10.1387/ijdb.041794hp Transcriptional regulation of cadherins during development and carcinogenesis 

  24. BioEssays: News Rev. Mol. Cell. Dev. Biol. Kohno 25 691 2003 10.1002/bies.10300 The pleiotropic functions of the Y-box-binding protein, YB-1 

  25. Biochem. Biokhim. Eliseeva 76 1402 2011 10.1134/S0006297911130049 Y-box-binding protein 1 (YB-1) and its functions 

  26. Mod. Pathol.: Off. J. US Can. Acad. Pathol. Inc. Tay 22 282 2009 10.1038/modpathol.2008.181 Y-Box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer 

  27. RNA Liu 21 1159 2015 10.1261/rna.045559.114 Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells 

  28. Biomark. Med. Zhao 8 581 2014 10.2217/bmm.14.4 Association between higher expression of YB-1 and poor prognosis in early-stage extranodal nasal-type natural killer/T-cell lymphoma 

  29. Int. J. Cancer Lasham 139 1157 2016 10.1002/ijc.30137 A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line 

  30. Oncotarget Zhao 7 82139 2016 10.18632/oncotarget.10080 YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma 

  31. Cancer Res. To 70 2840 2010 10.1158/0008-5472.CAN-09-3155 Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance 

  32. J. Surg. Oncol. Wu 105 724 2012 10.1002/jso.23030 Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer 

  33. Cancer Cell Evdokimova 15 402 2009 10.1016/j.ccr.2009.03.017 Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition 

  34. J. Biol. Chem. Higashi 278 43470 2003 10.1074/jbc.M302339200 Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3 

  35. Cell Tissue Res. Xiong 355 365 2014 10.1007/s00441-013-1752-1 NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer 

  36. Oncotarget Gopal 6 13718 2015 10.18632/oncotarget.3764 YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment 

  37. BMC Cancer Jung 14 328 2014 10.1186/1471-2407-14-328 YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells 

  38. Clin. Lung Cancer Hyogotani 13 375 2012 10.1016/j.cllc.2011.11.006 Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer 

  39. Carcinogenesis Tian 36 41 2015 10.1093/carcin/bgu230 Junctional adhesion molecule-A, an epithelial-mesenchymal transition inducer, correlates with metastasis and poor prognosis in human nasopharyngeal cancer 

  40. Gynecol. Oncol. Nishio 132 703 2014 10.1016/j.ygyno.2014.01.045 Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer 

  41. BMC Cancer Lim 17 201 2017 10.1186/s12885-017-3187-7 YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro 

  42. Oncotarget Prabhu 6 29396 2015 10.18632/oncotarget.5120 Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-kappaB in colon cancer 

  43. J. Exp. Clin. Cancer Res.: CR Zhang 35 109 2016 10.1186/s13046-016-0384-1 YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/beta-catenin signaling pathway 

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로